India’s liberalized policy has opened doors for participation of the most  business organizations of the  globe. The current scenario of economic growth reflects the vision of India’s policy. India is enjoying mostly because of investment of foreign money in various sectors . Most of the organizations, in turn, made impressive growth virtually in a reasonable span of time in their individual sectors.

When we, similarly consider only pharmaceutical business , most multinationals were already present in India before liberalization. In order to expand further their business with ever increasing number of products, they started either collaboration or licensing the products to a large number of Indian organized sector companies. The thought behind this were their impossibilities involved in marketing or promoting a large number of products with good support even floating many divisions. This way India not only gained ground but also raised its economy vibrantly which is at present hovering around, an all time record. Additionally, technology transfer to many Indian companies are also projecting undoubtedly a notable fillip too !

WISCON Pharmaceuticals Private Ltd, a wholly subsidiary Company, too participated in the Pharma sector to harvest inherent potentials in India, having expertise in marketing of many therapeutic segments globally.

The manufacturing agreements have been finalized with a number of WHO GMP and ISO 9001 -2000 certified companies for certain specialized products and to leverage their expertise in bringing to the medical fraternity technologically superior products. Its product portfolio predominantly is in line around child’s Healthcare and allied products with its global vision. Additionally WISCON has its dominant presence in Family Physicians, Consulting Physicians, Gynae , surgery and anti malarial markets.The product formulations shall comprise Syrups/Drops, tablets, capsules, Nasal Sprays/Rubs and injectables .

WISCON’s strategy for growth is to enter the market to leverage its global expertise in pharmaceutical marketing with regional strategy and to bring about a proper synergy in marketing. WISCON has bought over the Brands marketed by a reputed Company in  India having a strong portfolio in Child Care and allied products in line with WISCON's global portfolio . As a part of its organic and inorganic growth strategy this acquisition is a step towards attaining a leadership position in child care products in Indian market.

India as on date produces USD 10 Billion worth of medicines registering an exponential growth during the last six decades from a very nascent stage. The growth is highly significant but unfortunately the existing scenario does reflect that 60% of the population even today could not afford allopathic medicines. This is undoubtedly a hard fact even in presence of sustained country’s growth of economy and employment as against a rising population.

WISCON’S MISSION FOR INDIA IS TO ACCESS ITS PRODUCTS TO ALL THE PARTS OF THE COUNTRY INCLUDING RURAL AREAS WITH QUALITY AT AN AFFORDABLE PRICE .

THE VISION OF WISCON IS TO ATTAIN LEADERSHIP IN CHILDCARE PRODUCTS WITH A HIGH PROFILE OF IMAGE.
home profile news contact products qualitypolicy mktg doctor careers